Skip to content

Medrhythms, Inc.

United Statesfrom the FDA registration address FDA FEI 3014661062

Devices
6
Registrations
FDA
FDA recalls
0

At a glance

Counted by deviCERTS from registry records

Market reach

United States
FDA FEI

What Medrhythms, Inc. makes

Medrhythms, Inc. develops software solutions focused on neuromuscular rehabilitation, including tools designed to assess and improve motor function and coordination. Their products include systems for both clinical and educational use, such as platforms for rehabilitation exercises and training modules for physical therapy.

The company’s portfolio consists of Class II medical devices, all of which are listed in the FDA’s Unique Device Identifier (UDI) database. These products are regulated under U.S. medical device laws, adhering to the requirements for software-as-a-medical-device (SaMD) classifications.

AI-generated from registry data, 19 Sep 2026. Not verified by deviCERTS or the manufacturer.

Catalogue6

Newest first, rows 1-6 of 6

Company details

FDA FEI number
3014661062
DUNS number
080565076
Address
183 Middle Street, Portland, ME, 04101

Frequently asked questions

How many devices does Medrhythms, Inc. have in the registry?

The registry currently lists 6 devices for Medrhythms, Inc.. Devices recorded under merged duplicate company entries are counted once.

Which registries list Medrhythms, Inc.'s devices?

Among its 6 most recently registered devices, Medrhythms, Inc. has devices listed in FDA GUDID (6 devices).

What risk classes do Medrhythms, Inc.'s devices fall under?

Among its 6 most recently registered devices, the classes recorded for Medrhythms, Inc.'s devices are Class II. Each device page shows its own class and authorisation.

What are the newest devices from Medrhythms, Inc. in the registry?

The most recently registered devices listed for Medrhythms, Inc. include InTandem 001PRF, Movive 005PRF, InTandem 0010 and Movive Education Unit 005EDU.

Generated automatically from registry data and not verified by a human reviewer.